🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
China to establish scientific collaborative research platform for eye diseases
Therapeutics | News | 0 Comment | 19 Jun, 2023
The Hong Kong Polytechnic University (PolyU) has joined hands with Tianjin Medical University (TMU), China to nurture ta...Read more
China translates blood’s hidden gem Neutrophil into new generation anti-cancer therapy
Therapeutics | News | 0 Comment | 14 Jun, 2023
Lung cancer remains the most common cancer in Hong Kong. As a leading cancer killer worldwide, its treatment still needs...Read more
Triggering a collaborative initiative to accelerate biomedical R&D in South East Asia
Therapeutics | Opinion | 0 Comment | 09 Jun, 2023
Researchers in Asia are increasingly evaluating the significance and scope of proteomics in biomolecular discovery effor...Read more
Singapore develops technique to accelerate discovery of new immunotherapies
Therapeutics | News | 0 Comment | 08 Jun, 2023
A team of researchers from the National University of Singapore (NUS) led by Assistant Professor Cheow Lih Feng from the...Read more
Singapore discovers novel therapy to counter antibiotic-resistant lung infections
Therapeutics | News | 0 Comment | 06 Jun, 2023
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...Read more
Singapore uses AI to accelerate discovery of biomarkers for chronic myeloid leukaemia treatment
Therapeutics | News | 0 Comment | 02 Jun, 2023
Scientists at Duke-NUS Medical School, A*STAR’s Genome Institute of Singapore (GIS), Singapore General Hospital (S...Read more
Hong Kong to establish state-of-the-art facility for advanced cell therapies
Therapeutics | News | 0 Comment | 29 May, 2023
The Hong Kong Science and Technology Parks Corporation (HKSTP, a public corporation set up by the Hong Kong Government) ...Read more
Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial
Therapeutics | News | 0 Comment | 30 May, 2023
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...Read more
Korea-US partnership to co-develop therapy for Parkinson's Disease
Therapeutics | News | 0 Comment | 26 May, 2023
South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...Read more
Australia to create biobank of different phages for killing superbugs
Therapeutics | News | 0 Comment | 25 May, 2023
In a modern take on the Victorian gold rush, a Monash University-led project is successfully ‘bioprospecting&rsquo...Read more
China suggests use of non-invasive biomarkers for colorectal cancer screening
Therapeutics | News | 0 Comment | 11 May, 2023
The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) led a team of a dozen international...Read more
Singapore's CytoMed Therapeutics announces collaboration with MD Anderson Cancer Center in US
Therapeutics | News | 0 Comment | 11 May, 2023
Singapore based startup CytoMed Therapeutics, spun off from the Agency for Science, Technology and Research (A*STAR), ha...Read more
Junshi Biosciences, Dr. Reddy’s to develop and commercialise oncology drug in 21 countries
Therapeutics | News | 3 Comment | 08 May, 2023
Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratories to devel...Read more
New Zealand runs trial to fix gut problems in autistic people
Therapeutics | News | 0 Comment | 08 May, 2023
A ground-breaking clinical trial involving microbiome transfer to alleviate gut problems in Autistic people is starting ...Read more
Hong Kong researchers suggest HCMV detection in urine as routine test for HIV-1 patients
Therapeutics | News | 0 Comment | 05 May, 2023
A Hong Kong Baptist University (HKBU) collaborative research team has shown that urine tests for human cytomegalovirus (...Read more
“As Precision Medicine is critical, we cannot think about one size fits all”
Therapeutics | Opinion | 0 Comment | 03 May, 2023
Can you explain what GPCR heteromers are and why they are a promising target for cancer therapeutics? Before I answer y...Read more
How Radiopharmaceuticals Are Transforming Cancer Treatment
Therapeutics | Analysis | By Ayesha Siddiqui | 2 Comment | 03 May, 2023
A key goal for any innovative cancer treatment is the ability to deliver an anti-cancer agent directly to the tumour and...Read more
MicrofluidX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies
Therapeutics | News | 0 Comment | 02 May, 2023
MicrofluidX, a UK-based provider of next generation bioreactors for cell biology research and cell therapy manufac...Read more